baber/WOPTO huggingface dataset:
Patent CA-2548818-A1 (CA)
Title: Flexible vandal-resistant panels
Inventor: MARKER WILLIAM C
IPC: F16S1/10
Filed: 1999-03-16
Abstract: A strong, flexible and vandalism-resistant panel is provided. The panel includes a flexible wire skeleton structure such as a chain link structure embedded in a layer of polymer material such as rubber, synthetic rubber of another suitable polymer material. The chain link structure is made from parallel flat helical link sections connected by curved cross-sections. The panel of the present invention is particularly useful as a curtain for a roll-up door or for panels used to cover the space disposed between two adjacent railroad car sections. The formed panels are flexible, cannot be dented, are substantially cut-proof and are highly vandalism-resistant.
Patent CA-2549426-A1 (CA)
Inventor: ALBECK MICHAEL
IPC: A01K/
Filed: 2004-12-09
Abstract: A method for the direct or adjunct treatment of bacterial or fungal infections in fish and crustaceans including shell fish which is based on providing an effective amount of an organic tellurium compound in an aqueous environment to which said fish or crustaceans are exposed.
Patent CA-2551025-A1 (CA)
Inventor: ROLFS DAMON MICHAEL
IPC: G06F9/44
Filed: 2002-05-17
Abstract: An application framework for use with netcentric application program architectures, the application framework comprising: a server computer configured to receive a user event during a conversation that comprises a cohesive set of web pages; a servlet operable on the server computer that is enabled by the conversation and responsive to the user event, the servlet comprising: a document that defines a selector associated with the user event, wherein the selector is a logical expression that enables access to a web page when predefined conditions have been met; a begin response element executable with the server computer to access the document and evaluate if the selector associated with the user event is true or false; and a business logic executable on the server computer, wherein the servlet is configured to work with a plurality of components included in the business logic only when the selector evaluates to true.
Patent CA-2555492-A1 (CA)
Inventor: BRADLEY PATRICIA
IPC: A63H33/04
Filed: 2006-08-04
Abstract: A toy is provided employing mouldable material and three-dimensional structures having recessed regions for receiving and retaining quantities of the mouldable material. The mouldable material is releasably attachable to the structure to give the structure a decorative coating. If, after initial attachment, the appearance of mouldable material on the structure is unsatisfactory, the mouldable material may be removed and reapplied to the same structure or to another structure.
Patent CA-2560185-A1 (CA)
Title: Novel assay for the separation and quantification of hemagglutinin antigens
Inventor: KAPTEYN JOHAN CHRISTIAAN
IPC: A61K39/145
Filed: 2005-03-03
Abstract: The present invention relates to novel methods for separating hemagglutinin (HA) antigens, comprising the steps of applying a reduced and derivatized antigen preparation comprising solubilized HA antigens and a detergent in a pH  controlled solution, on a Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) column; and eluting the HA antigens from the column with an ion pairing agent in an organic mobile phase. The invention further relates to quantifying methods using the methods for separating the antigens with the further step of measuring the peak area of the eluted antigen in a chromatogram resulting from the elution step.
Patent CA-2560365-A1 (CA)
Inventor: CHUNG KIOSKY
IPC: F24C3/08
Filed: 2006-09-20
Abstract: A lateral burner includes a case attached to a wall of a barbecue stove and connected to a pipe of the barbecue stove. A conduit is attached to the case for sending gas therein from the pipe and made with apertures through which the gas is sent. A heat-transferring plate is placed before the conduit and made with apertures through which the gas is sent. A  ceramic plate is placed before the heat-transferring plate for protection against wind. The ceramic plate defines apertures through which the gas is sent. An igniter is placed before the ceramic plate for igniting the gas sent through the apertures of the ceramic plate. A front fender is placed before the igniter for protection against wind.
Patent CA-2562929-A1 (CA)
Title: Support structure for a retractable and extendable flap, and use of said structure
Inventor: REIPRICH MICHAEL
IPC: B64C9/16
Filed: 2004-08-05
Abstract: The invention relates to a support structure for a retractable and extendable flap (12) that is associated with an object (14) surrounded by a flowing liquid. Said support structure has a shell profile (16) that has a fluid/aerodynamic form on the outer side and a chamber (18), on the inner side, for at least partially receiving a device (20) for the retraction and extension of the flap (12).
Patent CA-2563281-A1 (CA)
Inventor: FUJIMOTO AKIHISA
IPC: G06F1/26
Filed: 2005-11-25
Abstract: A host device (2) reads out information from a card (1) and writes informati on in the card. The host device can supply a power supply voltage which belongs to either a first voltage range or a second voltage range smaller than the first voltage range, and issues a voltage discriminating command (CMDV) to t he card. The voltage discriminating command includes a voltage range discriminating section (VOLS), an error detecting section (ED) and a check pattern section (CPS). The voltage range discriminating section includes information indicating to which of the ranges, namely, the first voltage ran ge or the second voltage range, the power supply voltage belongs. The error detecting section has a pattern configured to permit the card which received the voltage discriminating command to detect an error of the voltage discriminating command. The check pattern section has a pattern previously s et.
Patent CA-2564160-A1 (CA)
Title: Water-cooled vertical engine and outboard motor equipped therewith
Inventor: TAWA HIROKI
IPC: B63H20/00
Filed: 2003-10-06
Abstract: An outboard motor water-cooled vertical engine is provided in which a crankshaft is disposed substantially vertically, a timing chain for transmitting a driving force of the crankshaft to a camshaft is disposed in an upper part of the cylinder block and a cylinder head, and an upper part of the timing chain is covered with a chain cover. Provided in the chain cover are thermostats for controlling the flow of cooling water in a cylinder block cooling water jacket and a cylinder head cooling water jacket. Therefore, the thermostats can be accessed from the top of the engine for maintenance without being obstructed by the timing chain, and moreover it is easy to manipulate a drain pipe for discharging cooling water from the thermostats.
Patent CA-2564613-A1 (CA)
Title: Pseudopeptides growth hormone secretagogues
Inventor: DEGHENGHI ROMANO
IPC: A61K38/00
Filed: 2005-04-21
Abstract: The present invention relates to novel growth hormone releasing pseudopeptides capable of stimulating the release of growth hormone from the pituitary and of promoting growth in mammals. The invention also provides pharmaceutical compositions comprising the pseudopeptides growth hormone secretagogues and a method for promoting the release of growth hormone in mammals. If continuously administered, the present pseudopeptides may also inhibit the release of growth hormone by down-regulating the growth response. An exemplary pseudopeptide compound of this invention is Aib-D-Trp-D-Trppsi[CH2-NH-O]Gly-NH2 (IIa).
Patent CA-2571840-A1 (CA)
Title: Gift registry system and method therefor
Inventor: STARK DEAN
IPC: G06Q30/06
Filed: 2006-12-20
Abstract: A gift registry system is provided. The system comprises a data store configured to store an item code and an item description associated with the item code. The item code corresponds to an item available for selection at a gift seller's establishment and is displayed in conjunction with the item. The system also comprises a portable registry unit in communication with the data store. The registry unit configured to receive the item code entered by a registrant while attending the gift seller's establishment, acquire from the data store the corresponding item description, present the acquired item description to the registrant, and, communicate an update-registry instruction to effect an update of the gift registry. The system also comprises a registry module that is in communication with the registry unit. The registry module configured to receive the update-registry instruction from the registry unit, and update the gift registry in accordance with the received instruction. A corresponding method is also provided.
Patent CA-2576044-A1 (CA)
Inventor: WOHLRAB WALTER
IPC: F16C29/02
Filed: 2005-08-05
Abstract: The invention relates to a closing unit, particularly for an injection moulding machine, comprising at least one moveable mould clamping plate (10) which is moveably arranged on a frame element (40). Lubrication is provided between the mould clamping plate (10) and the frame element (40) in order to facilitate displacement to and fro. At least one hydrostatic bearing arrangement is provided in at least one position between the mould clamping plate (10) and frame element (40) in order to avoid speed-dependent friction values normally associated with hydrodynamic bearings. The invention also relates to a method for the operation of a closing unit, wherein a pressure is built up in the hydrostatic bearing arrangement prior to displacement of the moveable mould clamping plate (10), the moveable mould clamping plate (10) is displaced and the pressure for the hydrostatic bearing arrangement is decreased after displacement.
Patent CA-2579172-A1 (CA)
Inventor: COLLETT RICHI
IPC: A61F2/00
Filed: 2005-07-07
Abstract: According to the present application, a medical package including a container (1) and a medical component (6), in particular a dental implant component, is disclosed. Said container (1) in a closed position thereof forms a component compartment (2) for said medical component (6) and an access channel (5) for an external instrument. Said access channel (5) is dimensioned to prevent said component (6) from passing through the access channel (5) and to allow said instrument to be inserted through the channel (5) and brought into engagement with the component (6) while the container (1) is in its closed position. Said container (1) is transferable to an open position while maintaining said engagement of the external instrument with the component (6), and said component (6), in the open position of said container (1), is removable from the container (1) by said external instrument. Furthermore, a medical package system including an external instrument, a container (1) and methods for removing a medical component (6) from a container (1) are disclosed.
Patent CA-2579537-A1 (CA)
Title: Dye-sensitized photoelectric conversion devices
Inventor: INOUE TERUHISA
IPC: H01L31/04
Filed: 2005-09-06
Abstract: Photoelectric conversion devices, characterized by being made by using oxide semiconductor particles sensitized with a methine dye represented by the general formula (1); and solar batteries made by using the same: [wherein m is an integer of 1 to 4; n1 is an integer of 1 to 7; p1 is an integer of 1 to 4;  X1 is an optionally substituted aromatic residue, an optionally substituted aliphatic hydrocarbon residue, cyano, phosphono, sulfo, carboxy, carbonamido, or the like; L1 is an optionally substituted aromatic residue or the like; A1 and A2 are each independently an optionally substituted aromatic residue, hydroxy, phosphono, cyano, hydrogen, halogeno, or the like; and the ring a1 has one or more substituents selected from among halogeno, amido, hydroxy, cyano, nitro, alkoxy, acyl, and so on]. The devices and the batteries are characterized by relatively low cost, high stability, and high photoelectric conversion efficiency.
Patent CA-2580831-A1 (CA)
Inventor: METZ WILLIAM A
IPC: C07D519/00
Filed: 2005-09-29
Abstract: L'invention concerne les nouveaux produits de formule (I), dans laquelle : Rl représente hydrogène, alkyle et alkényle éventuellement substitués ; R2 représente alcoxy et R3 représente alkyle ou alcoxy ; R4 représente hydrogène;  halogène; dioxolanne; -CH=O; -CH=N-OH; -CH=N-phényl avec phényl éventuellement substitué ; cyano, alkyle et alcoxy éventuellement substitués; R5 représente hydrogène ou halogène, tous ces radicaux étant éventuellement substitués, ces produits étant sous toutes les formes isomères et les sels, à titre de médicaments.
Patent CA-2581978-A1 (CA)
Title: Metallurgical furnace
Inventor: KOJO ILKKA
IPC: F27D1/04
Filed: 2005-10-11
Abstract: The invention relates to the structure of the bottom area of a metallurgical furnace (1), comprising a bottom part (2) and a wall (3), both of which include a steel structure (6, 21) forming the external surface, and a refractory inner brick lining (12), the bottom part (2) and the wall (3) being joined together; the wall (3) of the furnace (1) is divided into a lower part (4) and an upper part (30), whereby the steel structure (21) of the lower part (4) is a separate ring consisting of parts (23), joints (19) being provided between the parts (23) and arranged to expand. The invention further relates to a method for controlling the expansion of the furnace (1).
Patent CA-2583520-A1 (CA)
Title: Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
Inventor: PIPERDI BILAL
IPC: A61K31/517
Filed: 2005-10-18
Abstract: The present invention provides a method for method for manufacturing a medicament intended for treating tumors or tumor metastases in a patient, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and bortezomib is used, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and bortezomib combination in a combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCI (also known as Tarceva TM).
Patent CA-2585427-A1 (CA)
Title: Color compensating retinal safety filter
Inventor: ARTSYUKHOVICH ALEXANDER N
IPC: A61F9/00
Filed: 2005-10-26
Abstract: A filter and method for filtering an optical beam are disclosed. One embodiment of the filter is an optical filter for filtering an incident light beam, comprising an optically effective material characterized by: a light transmittance of less than 1% for wavelengths below 420 nm; and a light transmittance for wavelengths complementary and near complementary to wavelengths below 420 nm that, combined with the transmittance for wavelengths below 420 nm, will yield a filtered light beam having a luminosity of about 90% and an excitation purity of 5% or less. The complementary wavelengths can be wavelengths above about 640 nm, wavelengths above about 660 nm, and/or wavelengths from about 540 nm to about 560 nm. Further, in one embodiment the difference between the light transmittance just below 420 nm and the light transmittance just above 420 nm can be greater than 90%. Above 420 nm, in some embodiments, the light transmittance can be arbitrarily determined.
Patent CA-2586092-A1 (CA)
Inventor: ROUSSEAU FRANCIS
IPC: C12Q1/68
Filed: 2005-11-21
Abstract: The present invention more particularly discloses the identification of a human obesity susceptibility gene, which can be used for the diagnosis, prevention and treatment of obesity and associated disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses certain alleles of the contactin associated protein-like 2 (CNTNAP2) gene related to susceptibility to obesity and representing novel targets for therapeutic intervention. The present invention relates to particular mutations in the CNTNAP2 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including but not limited to hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and associated complications and dyslipidemia.
Patent CA-2587187-A1 (CA)
Title: Treatment of mastitis with enrofloxacin
Inventor: FROYMAN ROBRECHT
IPC: A61P13/00
Filed: 2005-10-28
Abstract: The invention relates to the simplified treatment of mastitis, with enrofloxacin or ciprofloxacin, in particular, in cattle.
Patent CA-2588276-A1 (CA)
Inventor: SHEARIN DOUGLAS M
IPC: F17C1/02
Filed: 2007-05-09
Abstract: A container assembly having a tank with first and second sides for storing materials under pressure. A plurality of hoop stringers surround each half of the tank and cross one another to define joints The hoop stringers extend radially outward at various points, including the crossing of the hoop stringers, to increase a cross sectional area of the hoop stringers.
Patent CA-2588454-A1 (CA)
Title: Formulations of substituted benzoxazoles
Inventor: TESCONI MARC S
IPC: A61K31/4164
Filed: 2005-11-30
Abstract: The present invention provides solid dosage formulations of benzoxazole-containing Er~-selective ligands, and processes for their manufacture, more particularly to novel formulations, and processes for their manufacture, that contain the ER~-selective ligand, ERB-041.
Patent CA-2588789-A1 (CA)
Inventor: MALONEY RIAN R
IPC: G06K9/00
Filed: 2005-11-10
Abstract: Dans un mode de réalisation, l'invention concerne un logiciel exemplaire qui peut déterminer une première valeur de hachage pour une image électronique de chèque, ladite image de chèque pouvant générer un document de remplacement d'image. La valeur de hachage est associée à l'image de chèque électronique. L'image de chèque électronique et la valeur de hachage associée sont communiquées à un destinataire aux fins de traitement.
Patent CA-2588963-A1 (CA)
Title: 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
Inventor: FUSHIMI NOBUHIKO
IPC: A61K38/00
Filed: 2005-11-17
Abstract: The invention provides compounds which exhibit inhibitory activity against SGLT1 and/or SGLT2 and are useful as preventive or therapeutic drugs for diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, and so on. 1-Substituted-3-.beta.-D-glucopyranosylated nitrogenous hetero- cyclic compounds represented by the general formula (I), prodrugs or pharmacologically acceptable salts of the same, or hydrates or solvates of them; SGLT inhibitors containing the same; medicines containing the inhibitors; and combined pharmaceutical preparations containing the same:  (I) wherein A is alkylene or alkenylene; Bis a single bond, -O-, -S-, or -NH-;  C is optionally substituted, aryl or heteroaryl; and Q's are each independently a carbon or nitrogen atom to which hydrogen or a substituent is bonded.
Patent CA-2590759-A1 (CA)
Inventor: DENNIS STEPHEN R
IPC: B65D53/04
Filed: 2007-05-31
Abstract: Provided is a liner material that includes a substrate layer, an active material absorbed into or overlying the substrate layer, and a first protective layer overlying the active material on the top surface of said substrate layer. Optionally, a second protective layer underlies the bottom surface of the substrate layer. The protective layers are impermeable to the active material and are water-soluble. The protective layer precludes release of the active material from the substrate layer so long as the protective layers are intact and undissolved.
Patent CA-2591117-A1 (CA)
Title: Novel heteroarylacetamides
Inventor: HAAP WOLFGANG
IPC: C07D417/14
Filed: 2005-12-14
Abstract: The invention is concerned with novel heteroarylacetamides of formula (I) Rd-C(O)-N(Re)-Rc-CH2-C(O)-N(Ra)(Rb), wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
Patent CA-2591148-A1 (CA)
Title: Anti-integrin immunoconjugates, methods and uses
Inventor: CHEN QIMING
IPC: C07K16/46
Filed: 2005-11-30
Abstract: The invention relates to conjugates of anti-integrin specific antibodies with cytotoxic compounds, the synthesis, selection, and use of such conjugates for use in cancer therapy or other diseases mediated by cell proliferation, cell migration, or inflammation and which pathology involves angiogenesis or neovascularization of new tissue. In addition the invention relates to combination therapy of such diseases wherein the treatment comprises use of said conjugates in combination with one or more other treatment modalities including but not limited to: chemotherapy, surgery or radiation therapy. The preferred conjugates contain maytansinoid compounds linked to the antibody by a disulfide linkage, and preferred chemotherapeutic agents are doxorubicin, a taxane, a camptothecin, a podophyllotoxin, a nucleoside analog, or a pyrimidine analog.
Patent CA-2591714-A1 (CA)
Inventor: MASSINGILL JOHN LEE
IPC: B01D11/00
Filed: 2005-12-22
Abstract: A fiber reaction process whereby reactive components contained in immiscible streams are brought into contact to effect chemical reactions and separations. The conduit reactor utilized contains wettable fibers into which one stream is substantially constrained and a second stream is flowed over to continuously create a new interface there between to efficiently bring about contact of the reactive species and thus promote reactions thereof or extractions thereby. Co-solvents and phase transfer catalysts may be employed to facilitate the process.
Patent CA-2592110-A1 (CA)
Inventor: CORTEZ JOSE
IPC: F16L37/32
Filed: 2006-01-03
Abstract: The integrated jet fluid level shutoff sensor vent assembly is designed for use in conjunction with a non-pressurizing tank fast fill system, and to support automatic shutoff fast fill refueling of vehicles. The integrated jet fluid level shutoff sensor vent assembly is mounted to a fuel tank and exposed inside the fuel tank for sensing a predetermined level of fuel within the fuel tank and allowing fully vented refueling.
Patent CA-2592986-A1 (CA)
Inventor: HOOVER DENNIS JAY
IPC: C07D413/14
Filed: 2005-12-22
Abstract: The invention pertains to heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds which are selective inhibitors of PDE10. The invention also relates to intermediates for preparation of said compounds; pharmaceutical compositions comprising said compounds; and the use of said compounds in a method for treating certain central nervous system (CNS) or other disorders.